Invest in your health.

Beyond the Hype: Navigating the Ethics of the Modern Longevity Market

Picture of Michael Leone, MD

Michael Leone, MD

blog post

The quest for extended healthspan has birthed a burgeoning industry often referred to as “longevity medicine.” However, beneath the glossy marketing and celebrity endorsements lies a landscape that remains largely unregulated. As clinical practitioners, it is our moral imperative to distinguish evidence-based interventions from the “snake oil” currently saturating the marketplace.

The Wild West of Longevity

Currently, there is no governing board of longevity medicine and no standardized certification process. Any individual claiming the title of “longevity specialist” does so without a universally recognized credential to validate their expertise.

Compounding this issue is a regulatory loophole: many diagnostics and interventions are commercialized without being proven effective. By hiding behind “not intended for medical use” disclaimers, companies bypass rigorous clinical scrutiny. Even respected members of the scientific community have, at times, drifted away from traditional evidence-based medicine toward speculative, hype-driven claims. Consequently, the ethical burden of discernment has shifted unfairly from the provider to the consumer.

Identifying the “Snake Oil” Playbook

To protect patient health and financial resources, we must recognize the red flags of predatory longevity marketing:

  • Proprietary IV Cocktails: Marketing vitamin and NAD drips without clinical necessity.
  • Speculative Testing: Aggressive promotion of biological age tests and non-guideline-based cancer screenings.
  • Vertical Sales Models: Companies that process lab work only to “discover” deficiencies that can—conveniently—only be corrected by their own proprietary supplements.
  • Celebrity Over Science: Relying on influencers rather than peer-reviewed data to drive adoption.

The Data Myth: The Danger of “Shotgun” Testing

In traditional clinical practice, diagnostic tests are ordered based on pre-test probability. A physician uses a patient’s history to determine the likelihood of a condition before testing.

The “shotgun” approach favored by many longevity startups—ordering massive panels for rare genetic or autoimmune disorders—creates a dangerous amount of “noise.” With a 1-in-a-million chance of some diseases actually being present, this method dramatically increases the risk of false positives. This leads to unnecessary anxiety, over-treatment, and a data set that even a skilled physician cannot effectively interpret.

Why Data Requires a Physician’s Lens

Data in isolation is not healthcare; it is noise. A clinician with a strong background is essential to take a proper history and judiciously decide which tests provide actual value.

Attempting to manage complex health data without a doctor is akin to managing significant wealth without a financial expert: it is inherently risky and often leads to poorer outcomes. Without the diagnostic framework that physicians possess, a patient may miss a critical, actionable result while being distracted by irrelevant data points.

The delaeMD Standard: Evidence-First Healthspan Medicine

At delaeMD, we reject the “Wild West” approach in favor of clinical integrity:

  • Long-Term Physician Partnerships: We pair clients with a dedicated physician who understands their unique history, risks, and goals.
  • Shared Decision-Making: We do not push non-guideline diagnostics. If an unproven but potentially useful intervention is considered, it is only after a transparent discussion of risks, benefits, and worst-case scenarios.
  • Education over Fear: Our priority is empowering clients through clinical literacy, not fear-mongering or hype.
  • Value-Based Care: By focusing only on interventions that truly “move the needle,” we provide concierge longevity care at 50% to 75% of the cost of hype-driven competitors.

Conclusion: Invest in Health, Not Hype

The longevity market is currently a “buyer beware” environment. To protect your well-being, trust your clinical intuition and prioritize services that pair you with a licensed, evidence-oriented physician. Your health is your most valuable asset; do not trade it for snake oil.

more insights

blog post

A Physician’s Guide to Using CGM to Detect Early Signs of Insulin Resistance

Summary:

The 1-hour post-prandial peak is a metric of insulin resistance, as consistently exceeding 155 mg/dL often predicts future diabetes risk even when your fasting lab results look normal.

A healthy post-prandial return-to-baseline occurs within 2 to 4 hours, serving as a real-time measure of how efficiently your muscles are clearing sugar from your blood.

Real-time biofeedback identifies your personal triggers, showing exactly how factors like poor sleep, acute stress, and post-meal movement impact your unique metabolic health.

Read more >
blog post

Wearable Health Data: Improving Outcomes with Physician Guidance

Summary:

Wearables become far more powerful when physicians interpret the data, turning raw numbers—like resting heart rate, steps, and sleep time—into meaningful, personalized guidance.

Long‑term trends from wearables help clinicians detect early changes in stress, recovery, sleep, and cardiovascular health, enabling more proactive and preventive care.

Patients achieve better outcomes when wearable data is paired with expert coaching, with studies showing improved activity, sleep habits, and engagement compared to using devices alone.

Read more >
blog post

Before You Buy Function Health: A Physician’s Perspective

Summary:

Many labs in large panels are already part of routine preventive care, but only a small number of additional tests have evidence to support screening in healthy, asymptomatic adults.

Broad, untargeted testing can cause harm through false positives, unnecessary follow‑up, anxiety, and care cascades—without improving long‑term health outcomes.

Effective prevention is about precision, not volume: ordering the right tests for the right person at the right time, guided by evidence and clinical context.

Read more >